IGF2BP2 and fatty liver disease: HFD-fed hepatocellular specific IGF2BP2 knockout mice have been found to exhibit reduced liver fatty acid oxidation, increased triglyceride accumulation, and moderate fatty liver disease, possibly due to significantly reduced expression levels of the CPT1A and PPARα (130).